<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

Mastering Your 401(k) to IRA Rollover: Essential Insights for Regeneron Pharmaceuticals Employees

image-table

Healthcare Provider Update: Healthcare Provider for Regeneron Pharmaceuticals: Regeneron Pharmaceuticals primarily collaborates with a range of healthcare providers, including hospitals, specialty clinics, and other medical organizations that focus on treating conditions related to its drug portfolio. The company often works with health systems, managed care organizations, and practices that specialize in therapeutic areas such as oncology, ophthalmology, and immunology, with notable partnerships aimed at advancing clinical research and access to its innovative treatments. Potential Healthcare Cost Increases in 2026: As we approach 2026, healthcare costs are projected to surge significantly, largely due to the anticipated expiration of enhanced federal subsidies under the Affordable Care Act and continued inflation in medical expenses. Reports suggest that some states may face premium hikes exceeding 60%, potentially increasing out-of-pocket costs for enrollees by up to 75%. This turbulence stems from a convergence of higher medical costs, substantial drug spending, and a regulatory landscape that pressures insurers to increase rates. Without timely congressional action to renew premium tax credits, many consumers could be priced out of affordable healthcare coverage. Click here to learn more

In the complex realm of retirement planning, a critical yet often overlooked issue is the unintentional delay of cash funds during the 401(k) to IRA conversion process. This seemingly minor oversight has profound consequences, costing American pensioners billions in unrealized investments. The phenomenon, where large sums remain un-invested, underscores a critical area of concern as the retirement savings landscape, including for those at Regeneron Pharmaceuticals, continues to evolve.


According to a study by  Vanguard Group , there's a notable trend: a significant portion of retirees transferring their 401(k) savings into Individual Retirement Accounts (IRA) fail to reinvest these funds into the market. Specifically, nearly half of Vanguard clients who moved their 401(k) accounts to IRAs in 2015 still held their funds in cash seven years later. This inertia is not just a minor incident but a significant financial loss, with Vanguard estimating an annual loss exceeding $172 billion in un-invested retirement funds. Regeneron Pharmaceuticals employees should be mindful of these trends and take pre-emptive measures to avoid this issue.

The default of payment after transfer is particularly pronounced among younger employees, who are accustomed to automated investment strategies in employer-sponsored employment plans. This group is particularly vulnerable to missing out on the cumulative benefits of early investment. However, the issue spans across ages, affecting older investors who, according to financial advisors, require some exposure to stocks to ensure the sustainability of their retirement funds.


This oversight is increasingly critical given the predominant role of IRAs in the American retirement system. With IRAs holding about $14.3 trillion in assets, surpassing the amount of $11.1 trillion in 401(k)-type plans according to data from the Investment Company Institute, the size of un-invested funds represents a major opportunity to generate wealth.

The rollover process typically involves liquidating 401(k) assets by the management company, which then transfers the funds to an IRA. While this procedure facilitates the transfer, it inadvertently assumes that the funds remain un-invested unless the account holder actively chooses new investments—a step many seem to overlook. According to a 2022 Vanguard study, more than half of IRA contributors left their funds in cash for at least one year.

The array of investment options available in IRAs, although beneficial for customizing investment strategies, can also overwhelm Regeneron Pharmaceuticals account holders, potentially leading to indecision. Furthermore, a prevalent notion that custodians such as Vanguard or Fidelity Investments automatically invest IRA contributions further exacerbates the issue. Frequently, large sums in IRAs remain consistently in cash, as confirmed by a Vanguard survey where 68% of IRA clients admitted they were unaware of their investment status.

Featured Video

Articles you may find interesting:

Loading...


The financial consequences are significant. With the Federal Reserve's interest rate hikes in 2022, cash investment yields have seen an increase, with money market funds offering about a 5% annual interest rate. However, compared to the historical earnings of major American corporations, which have recorded an average annual rate of 7.19% since 1926 according to  Morningstar Direct , the potential gains from proper investment management are considerable.

An essential element Regeneron Pharmaceuticals employees should consider during the 401(k) to IRA conversion process is the impact of tax consequences. According to the  IRS , if a rollover is not performed correctly, retirees could be taxed immediately on their 401(k) funds as ordinary income, which can reach up to 37%, depending on the tax bracket. Moreover, an incorrect rollover can result in a 10% early withdrawal penalty if under the age of 59½. These potential financial consequences highlight the importance of managing the rollover process carefully to preserve retirement savings. It is crucial to adhere to IRS rollover rules to avoid these costly penalties and taxes.

Consider transferring your 401(k) to an IRA without immediately investing the funds as akin to planting a garden but forgetting to water the seeds. Just as seeds require regular irrigation to flourish and thrive, your retirement savings need early investment to expand through the power of market earnings. Leaving your rollover funds in cash is like leaving the garden unattended—likely compromising potential growth and profits. It is crucial to ensure that your retirement funds are actively invested, just like a diligent gardener tending to their plants to enjoy a rich harvest.

What is the 401(k) plan offered by Regeneron Pharmaceuticals?

The 401(k) plan at Regeneron Pharmaceuticals is a retirement savings plan that allows employees to save a portion of their salary on a tax-deferred basis.

How can employees of Regeneron Pharmaceuticals enroll in the 401(k) plan?

Employees can enroll in the Regeneron Pharmaceuticals 401(k) plan by completing the enrollment process through the company’s HR portal or by contacting the HR department for assistance.

What types of contributions can employees make to the Regeneron Pharmaceuticals 401(k) plan?

Employees can make pre-tax contributions, Roth (after-tax) contributions, and potentially catch-up contributions if they are eligible.

Does Regeneron Pharmaceuticals offer a company match for the 401(k) contributions?

Yes, Regeneron Pharmaceuticals offers a company match for employee contributions to the 401(k) plan, which helps enhance retirement savings.

What is the vesting schedule for the Regeneron Pharmaceuticals 401(k) company match?

The vesting schedule for the company match in the Regeneron Pharmaceuticals 401(k) plan typically follows a graded vesting schedule, which employees can review in the plan documents.

Can employees take loans against their 401(k) savings at Regeneron Pharmaceuticals?

Yes, Regeneron Pharmaceuticals allows employees to take loans against their 401(k) savings, subject to specific terms and conditions outlined in the plan.

What investment options are available in the Regeneron Pharmaceuticals 401(k) plan?

The Regeneron Pharmaceuticals 401(k) plan offers a variety of investment options, including mutual funds, target-date funds, and other investment vehicles to suit different risk tolerances.

How often can employees change their contribution amounts to the Regeneron Pharmaceuticals 401(k) plan?

Employees can change their contribution amounts to the Regeneron Pharmaceuticals 401(k) plan at any time, subject to the plan's guidelines.

What happens to the 401(k) savings if an employee leaves Regeneron Pharmaceuticals?

If an employee leaves Regeneron Pharmaceuticals, they have several options for their 401(k) savings, including rolling over to another retirement account, cashing out, or leaving the funds in the plan if allowed.

Are there any fees associated with the Regeneron Pharmaceuticals 401(k) plan?

Yes, there may be fees associated with the Regeneron Pharmaceuticals 401(k) plan, including administrative fees and investment-related fees, which are disclosed in the plan documents.

New call-to-action

Additional Articles

Check Out Articles for Regeneron Pharmaceuticals employees

Loading...

For more information you can reach the plan administrator for Regeneron Pharmaceuticals at , ; or by calling them at .

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Regeneron Pharmaceuticals employees